170 related articles for article (PubMed ID: 20569707)
1. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.
Sherwood MW; Morrow DA; Scirica BM; Jiang S; Bode C; Rifai N; Gerszten RE; Gibson CM; Cannon CP; Braunwald E; Sabatine MS
Am Heart J; 2010 Jun; 159(6):964-971.e1. PubMed ID: 20569707
[TBL] [Abstract][Full Text] [Related]
2. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
Harkness JR; Sabatine MS; Braunwald E; Morrow DA; Sloan S; Wiviott SD; Giugliano RP; Antman EM; Cannon CP; Scirica BM
Am Heart J; 2010 Jan; 159(1):55-62. PubMed ID: 20102867
[TBL] [Abstract][Full Text] [Related]
3. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
Scirica BM; Sabatine MS; Morrow DA; Gibson CM; Murphy SA; Wiviott SD; Giugliano RP; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(1):37-42. PubMed ID: 16814646
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial.
Waks JW; Sabatine MS; Cannon CP; Morrow DA; Gibson CM; Wiviott SD; Giugliano RP; Sloan S; Scirica BM
Clin Cardiol; 2014 Mar; 37(3):160-6. PubMed ID: 24452727
[TBL] [Abstract][Full Text] [Related]
5. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
6. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis.
Ahmed S; Michael Gibson C; Cannon CP; Murphy SA; Sabatine MS
J Thromb Thrombolysis; 2011 May; 31(4):493-500. PubMed ID: 21318582
[TBL] [Abstract][Full Text] [Related]
7. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy.
O'Donoghue M; Morrow DA; Cannon CP; Guo W; Murphy SA; Gibson CM; Sabatine MS
Eur Heart J; 2008 Apr; 29(8):984-91. PubMed ID: 18346960
[TBL] [Abstract][Full Text] [Related]
8. Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction.
Björklund E; Lindahl B; Johanson P; Jernberg T; Svensson AM; Venge P; Wallentin L; Dellborg M;
Eur Heart J; 2004 Jan; 25(2):113-20. PubMed ID: 14720527
[TBL] [Abstract][Full Text] [Related]
9. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
10. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Lewis BS; Murphy SA; McCabe CH; Braunwald E;
JAMA; 2005 Sep; 294(10):1224-32. PubMed ID: 16143698
[TBL] [Abstract][Full Text] [Related]
11. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial.
Verheugt FW; Montalescot G; Sabatine MS; Soulat L; Lambert Y; Lapostolle F; Adgey J; Cannon CP
J Thromb Thrombolysis; 2007 Jun; 23(3):173-9. PubMed ID: 17160548
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
[TBL] [Abstract][Full Text] [Related]
14. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.
Scirica BM; Morrow DA; Sadowski Z; Ruda M; Nicolau JC; Giugliano RP; Wiviott SD; Sabatine MS; Shui A; Antman EM; Braunwald E
Eur Heart J; 2007 Sep; 28(17):2070-6. PubMed ID: 17600039
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
16. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
[TBL] [Abstract][Full Text] [Related]
17. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
[TBL] [Abstract][Full Text] [Related]
18. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
[TBL] [Abstract][Full Text] [Related]
19. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial.
Sabatine MS; McCabe CH; Gibson CM; Cannon CP
Am Heart J; 2005 Feb; 149(2):227-33. PubMed ID: 15846259
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
